Allergy Immunotherapy for Dogs: How It Works, Success Rates, Costs, and What to Expect
- 1 day ago
- 8 min read
Most allergy treatments for dogs work like turning down the volume. Allergen-specific immunotherapy (ASIT) is one of the few that’s trying to change the song.
In study reviews and teaching-hospital guidance, ASIT is repeatedly described as safe and commonly helpful—but not a guaranteed fix, with reported response rates often landing around 50–80%, depending on how “success” is defined and which dogs were included. And when it works, it usually doesn’t work fast: many dogs don’t show clear improvement until 3–6 months, and it often takes 9–12 months to judge whether it’s truly worth continuing. That timeline isn’t a flaw in the plan—it’s the plan. It’s how immune retraining behaves in real biology.
This article explains what immunotherapy is actually doing, how vets decide who’s a good candidate, what testing can and can’t tell you, the difference between shots and sublingual options, and how to hold realistic expectations without losing hope.
What immunotherapy is really for (and what it isn’t)
In dogs, ASIT is primarily discussed for environmental allergies—most commonly canine atopic dermatitis (a chronic, inflammatory skin disease strongly associated with allergy). It’s not aimed at treating infections, and it’s not a primary therapy for food allergy. It sits inside the bigger world of environmental allergies in dogs—the pollen, dust mites, molds, and other invisible things that can make skin behave like it’s under constant attack.
The key promise of ASIT is not immediate relief. The promise is a shift in immune behavior over time—often described as increased immune tolerance. The dog is exposed to very small amounts of relevant allergens in a structured way so the immune system may become less “hair-trigger” about them.
That’s why veterinary dermatology sources often call ASIT the only disease-modifying (etiologic/causative) therapy for canine atopic dermatitis: it targets the allergic mechanism rather than only suppressing symptoms.
A useful mental model:
Symptom control meds: “Let’s quiet the inflammation/itch now.”
Immunotherapy: “Let’s teach the immune system to overreact less later.”
Many dogs end up using both—especially during the long runway before ASIT has a chance to show what it can do.
Vocabulary, because this topic is a soup of acronyms
You’ll see these terms used interchangeably in clinics and articles:
ASIT / AIT: Allergen-specific immunotherapy / allergen immunotherapy
SCIT: Subcutaneous immunotherapy (“allergy shots” under the skin)
SLIT: Sublingual immunotherapy (drops/spray given in the mouth, usually at home)
Hyposensitization / desensitization: older or alternate wording for the same overall strategy
Newer routes (like intralymphatic or epicutaneous) exist in the literature but are not the everyday standard for most dogs.
Who tends to be a good candidate?
ASIT is typically considered when a dog has ongoing or repeating environmental allergy signs and the goal is long-term control with fewer tradeoffs.
Dogs often get brought into the “immunotherapy conversation” when:
itching and skin inflammation are chronic or predictably seasonal year after year
the dog needs repeated courses of symptom-suppressing meds (or can’t tolerate them)
the household wants a steroid-sparing long-term plan
a veterinarian has evaluated other common causes of itch (parasites, infections, etc.) and the pattern fits atopic disease
Cornell’s guidance explicitly frames allergy testing and immunotherapy as options for severe allergies, which matches how many dermatology practices use it: not as a first tool for every itchy dog, but as a serious plan for long-term disease burden.
A calmer, less-discussed point: choosing ASIT is also choosing a relationship with time. It’s a commitment to reassessment rather than immediate verdicts.
Testing: necessary, imperfect, and more interpretive than people expect
To create immunotherapy, a vet needs a defensible list of allergens to include. That list is built using:
clinical history (what seasons? what environments? what body areas? what patterns?)
intradermal testing (small amounts injected into the skin to look for a reaction)
and/or serum IgE testing (a blood test for allergen-specific IgE)
This is where a lot of owner confusion—and later disappointment—tends to begin.
The paradox: “positive” doesn’t always mean “relevant”
The literature emphasizes that allergen choice depends on history plus testing, not testing alone. Dogs can test positive to things they’re not meaningfully exposed to, or that aren’t the main drivers of their symptoms. And because ASIT’s success depends heavily on picking the right allergens, this interpretive step is one of the biggest uncertainties in the whole process.
If you’ve ever had the experience of getting test results that look like your dog is “allergic to the entire planet,” you’re not alone. It’s why a thoughtful discussion of dog allergy testing should include not just how tests work, but how vets decide what matters in your dog’s actual life.
A practical question that often improves the conversation with your vet:
SCIT vs SLIT: shots versus drops (and why the evidence feels uneven)
Both routes are trying to do the same thing—shift immune response—but they differ in practicality and in how mature the canine evidence base is.
Comparison at a glance
Feature | SCIT (shots) | SLIT (sublingual drops/spray) |
How it’s given | Injection under the skin | Drops/spray in the mouth/under tongue |
Where it’s done | Often at home after instruction, sometimes in clinic | Usually at home |
Evidence base in dogs | More established; commonly centered in veterinary summaries | Emerging/alternative; less standardized in dogs |
Biggest real-world hurdle | Comfort with injections + long-term adherence | Daily routine + less definitive canine data |
Pace of change | Slow | Slow |
In many veterinary summaries, “immunotherapy” is still essentially shorthand for SCIT because it’s the longest-established option in dogs. SLIT is often presented as a viable alternative when injections are a dealbreaker or when a clinician has good experience with it—but the research base is not as robust or standardized.
None of this means SLIT “doesn’t work.” It means that, compared to SCIT, there’s less agreement on best practices in dogs: dosing, formulation, and comparative outcomes under typical home conditions.
Timelines: the part nobody enjoys, but everyone needs
Immunotherapy is slow enough to mess with your confidence.
Commonly reported expectations:
Possible early improvement: around 3–6 months
Fair evaluation point: often 9–12 months, or at least a full year
Maintenance: can continue for years; some dogs stay on it long-term (sometimes lifelong), especially if it’s clearly helping
Why it feels emotionally strange
With antibiotics, you can see a turning point. With ASIT, the early months can look like: same dog, same itch, plus a new routine you’re working hard to keep.
That can trigger a very specific kind of caregiver thought spiral:
“If this is the ‘root cause’ treatment, why isn’t anything changing?”
“Did we pick the wrong allergens?”
“Am I doing it wrong?”
“Is my dog suffering because I chose the slow option?”
The science answer is boring but relieving: immune modulation tends to be gradual, and early months are often about building tolerance, not showing dramatic surface changes.
How effective is it, really? (The honest version)
Across reviews, clinical summaries, and teaching sources, the broad pattern is:
ASIT is often beneficial
not uniformly effective
and “success” is not one thing
Many sources cite ~60–80% of dogs responding “well enough to matter clinically,” and some papers/reviews land around ~70%. One summary breaks outcomes into a memorable, very human pattern:
~one-third near-complete responders
~one-third partial responders
~one-third limited responders (may still need meds during peak seasons)
There’s also a more numeric way some sources frame it: improvement in about 60% of dogs, with ~31.5% controlled and ~28.5% having a “good” response defined as >50% symptom reduction.
A gentle reality check about the evidence
A systemic review in JAVMA describes a good success rate and favorable long-term safety profile, while also noting a core issue: many studies are small and heterogeneous. A 2019 review similarly concludes ASIT is safe and effective but calls for better randomized trials to clarify optimal allergens, adjuvants, dosing, and clearer expected response rates.
So if you feel like you keep seeing different numbers, you’re reading the field accurately. The most honest consensus is not “it works in exactly X%,” but “many dogs benefit, some benefit a lot, and it’s hard to predict perfectly in advance.”
Safety: what “generally safe” actually means
ASIT is widely described as having a good safety profile, especially compared with long-term reliance on broader immunosuppressive drugs.
What’s most commonly reported:
increased pruritus (itching)—sometimes at the injection site, sometimes more generalized
What’s rare but important:
anaphylaxis, reported in one clinical summary as <1% of dogs
This is also why your vet’s instructions about observation after dosing (especially early on, or after changes) tend to be specific and non-negotiable.
The “medication-sparing” question (and why it matters to expectations)
A lot of families come to immunotherapy hoping for a life without other allergy meds.
Sometimes that happens. Often, something subtler happens—and it still counts:
fewer flare-ups
milder itch when flares happen
ability to use lower doses or fewer drugs
better skin stability across seasons
That’s part of why many dermatology sources describe ASIT as “drug-sparing.” Not because the dog never needs anything else, but because the baseline disease pressure may decrease.
If you’re also weighing symptomatic options—anti-itch meds, anti-inflammatories, antibiotics/antifungals when infections complicate things—it helps to think in layers rather than rivalry. There’s a practical place for dog allergy medications even when immunotherapy is the long game.
Day-to-day living while you’re waiting for ASIT to kick in
The months-long timeline is easier to tolerate when you have two parallel goals:
keep the dog comfortable enough today
reduce long-term reactivity over time
For many dogs, comfort today depends as much on reducing exposure and secondary triggers as it does on prescription choices. That’s where the unglamorous work—washing bedding, allergen-aware cleaning, humidity control, reducing dust mite load—can quietly change the background noise of the immune system. A thoughtful home environment approach doesn’t replace immunotherapy, but it can make the “waiting period” less punishing.
A grounded way to track progress (without losing your mind):
Keep a simple itch/skin diary (symptoms, season/weather, meds, infections, big changes).
Because ASIT’s changes can be gradual, memory can be an unreliable narrator.
The communication piece that makes everything easier
ASIT works best in a shared-decision model where everyone agrees ahead of time on what “worth it” would look like.
Helpful questions to bring to your vet or veterinary dermatologist:
“What outcome are we aiming for: fewer flares, less medication, or near-clear skin?”
“When will we reassess—at 6 months, 12 months?”
“If we’re seeing partial improvement, what changes would you consider: dose adjustments, allergen mix review, adding supportive meds seasonally?”
“What signs would make you worry about adverse reactions?”
This kind of clarity doesn’t reduce hope. It reduces the feeling that you’re guessing.
What’s well-established—and what’s still uncertain
Well-established in veterinary practice and reviews
ASIT is a standard option for canine environmental allergy/atopic dermatitis.
It’s generally safe and often helpful.
It takes months, not days.
It’s individualized based on history and testing.
Still uncertain (and worth naming out loud)
Best allergen selection strategies for every dog
optimal dosing/formulations and standardization across products
reliable predictors of strong response ahead of time
real-world comparative performance of SCIT vs SLIT
consistent response definitions across studies
Naming these uncertainties isn’t pessimism. It’s what keeps you from personalizing a slow or partial response as failure.
A final, steadier way to think about it
Immunotherapy is not a rescue rope; it’s a long bridge. It asks for routines, follow-up, and patience during months when the dog may look unchanged. But it also offers something rare in chronic allergy care: the possibility that next season doesn’t have to be a repeat of the last one—not because you fought harder, but because the immune system learned to calm down.
If you choose ASIT, the most useful expectation isn’t “this will cure my dog.” It’s “this may reduce the overall weight of the disease over time.” And for many dogs—and many tired, attentive owners—that’s not a small thing. It’s the difference between constant firefighting and a life that has room for other thoughts.
References
Quality of Life of Allergic Dogs Treated with Allergen-Specific Immunotherapy. PMC. https://pmc.ncbi.nlm.nih.gov/articles/PMC9965114/
University of Illinois Veterinary Medicine. Immunotherapy (Allergy Shots) for Dogs. https://vetmed.illinois.edu/pet-health-columns/immunotherapy-itchy-dog/
FirstVet. What is immunotherapy (ASIT) for dogs? https://firstvet.com/uk/articles/immunotherapy-dogs
The Dodo. Can Immunotherapy Help My Allergic Dog? https://www.thedodo.com/dodowell/allergy-shots-for-dogs
American Kennel Club (AKC). Immunotherapy (Allergy) Shots for Dogs: What to Know. https://www.akc.org/expert-advice/health/immunotherapy-allergy-shots-for-dogs/
Veterinary Skin & Ear. Allergy Immunotherapy. https://veterinaryskinandear.com/allergy-immunotherapy-hyposensitization-general-information/
GoodRx. Allergy Shots for Dogs. https://www.goodrx.com/pet-health/dog/do-allergy-shots-for-dogs-work
UW Veterinary Care. Immunotherapy (PDF). https://uwveterinarycare.wisc.edu/wp-content/uploads/2018/04/Immunotherapy-2018.pdf
Today’s Veterinary Practice. Allergen Immunotherapy for Canine Atopic Dermatitis: An Update. https://todaysveterinarypractice.com/dermatology/allergen-immunotherapy-for-canine-atopic-dermatitis/
Wilson’s Health. Dog Allergy Shots and Immunotherapy. https://www.wilsonshealth.com/post/dog-immunotherapy
Immunotherapy for pet allergies. PMC. https://pmc.ncbi.nlm.nih.gov/articles/PMC5893203/
AVMA Journals / JAVMA. Systematic review on allergen immunotherapy. https://avmajournals.avma.org/view/journals/javma/261/S1/javma.22.12.0576.xml
Stallergenes Greer Veterinary. Learn About Allergy Immunotherapy. https://www.stagrveterinaryallergy.com/allergyimmunotherapy/
Antech Diagnostics. Veterinary Allergy Therapy Shots. https://www.antechdiagnostics.com/allercept-therapy-shots/
Vet Derm Clinic. Allergen Immunotherapy for Atopic Dermatitis in Dogs. https://www.vetdermclinic.com/allergen-immunotherapy-for-atopic-dermatitis-in-dogs/
Petful. Allergy Shots for Dogs. https://www.petful.com/research/allergy-shots-for-dogs/
Allergen Specific Immunotherapy in Canine Atopic Dermatitis: an Update. SpringerLink. https://link.springer.com/article/10.1007/s13671-019-00276-z
Antech Diagnostics. Sublingual Immunotherapy for Pets (PDF). https://www.antechdiagnostics.com/wp-content/uploads/2025/01/UPDATED-SUBLINGUAL_IMMUNOTHERAPY_FOR_PETS-001.pdf
Cornell University Riney Canine Health Center. Allergy testing and immunotherapy. https://www.vet.cornell.edu/departments-centers-and-institutes/riney-canine-health-center/canine-health-topics/allergy-testing-and-immunotherapy
Vetclinic.info. Dog Allergy Shots: Cost, Success Rate, and How Long They Take to Work. https://vetclinic.info/procedures/immunotherapy/
PetLab Co. How Do Allergy Shots For Dogs Work? https://thepetlabco.com/learn/dog/health-wellness/how-do-allergy-shots-for-dogs-work/
Curex. Allergy Shots for Dog Allergies. https://getcurex.com/allergy-shots/guide/allergy-shots-for-dog-allergies"
Comments